Evidence map›Paper›PMID 28534864›Full record

ArticleMolecules (Basel, Switzerland)2017

Study on the Alkylation Reactions of N(7)-Unsubstituted 1,3-Diazaoxindoles.

Eszter Kókai, Judit Halász, András Dancsó, József Nagy, Gyula Simig, Balázs Volk

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Eszter KókaiDirectorate of Drug Substance Development, Egis Pharmaceuticals Plc., P.O. Box 100, 1475 Budapest, Hungary. ekokai@mail.bme.hu.
Judit HalászDirectorate of Drug Substance Development, Egis Pharmaceuticals Plc., P.O. Box 100, 1475 Budapest, Hungary. halasz.judit@egis.hu.
András DancsóDirectorate of Drug Substance Development, Egis Pharmaceuticals Plc., P.O. Box 100, 1475 Budapest, Hungary. dancso.andras@egis.hu.
József NagyDepartment of Organic Chemistry and Technology, Budapest University of Technology and Economics, P.O. Box 91, 1521 Budapest, Hungary. jozsefnagy@mail.bme.hu.
Gyula SimigDirectorate of Drug Substance Development, Egis Pharmaceuticals Plc., P.O. Box 100, 1475 Budapest, Hungary. simig.gyula@egis.hu.
Balázs VolkDirectorate of Drug Substance Development, Egis Pharmaceuticals Plc., P.O. Box 100, 1475 Budapest, Hungary. volk.balazs@egis.hu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The chemistry of the 5,7-dihydro-6

Indexed as

Chemistry Techniques, SyntheticAcetoneAlkenesAlkylationAza CompoundsBenzyl CompoundsCatalysisHydrocarbons, IodinatedIndolesOrganometallic CompoundsSodium HydroxideAcetoneAlkenesAza Compoundsbenzyl bromideBenzyl CompoundsbutyllithiumHydrocarbons, IodinatedIndolesmethyl iodideOrganometallic CompoundsSodium Hydroxide1,3-diazaoxindolesalkylationby-productslithiationregioselectivity

Identifiers

PMID28534864
PMCPMC6154441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.